申请人:Bounaud Pierre-Yves
公开号:US20140205537A1
公开(公告)日:2014-07-24
Provided herein are compounds that inhibit or partially inhibit the activity of leucine rich repeat kinases. Also provided herein are methods of treatment of CNS disorders comprising administration of inhibitors of leucine rich repeat kinases.
本文提供了抑制或部分抑制富含亮氨酸重复激酶活性的化合物。本文还提供了治疗中枢神经系统疾病的方法,包括给予富含亮氨酸重复激酶抑制剂的治疗。